Aandeel Aegon AEX:AGN.NL, BMG0112X1056

quote:

buf schreef op 11 december 2016 09:53:

dividend 2011 10 eurocent
dividend 2012 21 eurocent
dividend 2013 22 eurocent
dividend 2014 23 eurocent
dividend 2015 25 eurocent

int. div. 2016 13 eurocent

Vanaf 2011 is het dividend elk jaar verhoogd.
Gezien het int.div. kunnen we over 2016 dus op 26 a 27 eurocent rekenen.
Ik ben hier dik tevreden over.
Ik heb de aandelen in mei 2012 gekocht op 3,30.
Dus heb ik een riant dividendrendement op mijn investering, zeker in vergelijking met de rente op spaarrekeningen.
Een hoge koers is natuurlijk ook leuk maar voor mijzelf niet zo belangrijk.
Het dividend maak ik elk jaar zelf op en de aandelen zijn voor mijn nabestaanden.

quote:

buf schreef op 18 februari 2017 08:33:

nettowinst-onderliggende winst

1e kw. 2010 +372+446
2e kw. 2010 +413+522
3e kw. 2010 +657+473
4e kw. 2010 +318+489

1e kw. 2011 +327+441
2e kw. 2011 +404+401
3e kw. 2011 +060+361
4e kw. 2011 +081+346

1e kw. 2012 +521+425
2e kw. 2012 +254+443
3e kw. 2012 +374+472
4e kw. 2012 +422+447

1e kw. 2013 +204+445
2e kw. 2013 +243+478
3e kw. 2013 +227+531
4e kw. 2013 +174+491

1e kw. 2014 +392+498
2e kw. 2014 +343+514
3e kw. 2014 +052+291
4e kw. 2014 +399+562

1e kw. 2015 +316+469
2e kw. 2015 +350+549
3e kw. 2015 -524+436
4e kw. 2015 +478+486

1e kw. 2016 +143+462
2e kw. 2016 -385+435
3e kw. 2016 +358+461
4e kw. 2016 +470+554

Prima cijfers.
Alleen nu weer gezeik over de solvabiliteit in Nederland.
Altijd wat bij Aegon.

quote:

Bram7200 schreef op 6 mei 2017 11:50:

A.M. Best Revises Outlooks to Negative for Aegon N.V.'s U.S. Subsidiaries

OLDWICK, N.J.--(BUSINESS WIRE)-- A.M. Besthas revised the outlooks to negative from stable and affirmed the Financial Strength Rating (FSR) of A+ (Superior) and Long-Term Issuer Credit Ratings (Long-Term ICR) of "aa-" of the U.S. life/health subsidiaries of Aegon N.V.(Aegon) (Netherlands) [NYSE:AEG]. Aegon's U.S. life/health companies are collectively referred to as Aegon USA Group (Aegon USA). Concurrently, A.M. Best has affirmed the FSR of A (Excellent) and the Long-Term ICR of "a" of Transamerica Casualty Insurance Company (Transamerica Casualty) (Columbus, OH), the property/casualty member of Aegon USA. The outlook of this Credit Rating (rating) is stable.

The negative outlooks reflect a deterioration in A.M. Best's view of the credit profile of the ultimate holding company, Aegon, and its ability to sustain its current rating fundamentals over the medium term given the challenging operating environment for life insurers.

The rating affirmations of Aegon USA reflect its strong business profile, adequate risk-adjusted capitalization, well-developed enterprise risk management framework and an underlying trend of favorable statutory and IFRS profitability, although with some volatility given the asset and liability composition. The ratings also reflect A.M. Best's continued expectation of financial support from Aegon. Partially offsetting these strengths is the continued increasing focus on sales of variable annuities, which in A.M. Best's view have higher risk characteristics from a product creditworthiness standpoint. A.M. Best also notes the equity market sensitivity of the group's earnings and its significant reliance on captive reinsurance, which is a significant drag on the quality of the group's statutory capital.

Aegon USA's business profile continues to remain strong, with competitive market positions in the U.S. life and annuity arenas. The group's market positions are supported by a large and diversified distribution system. Product lines that contribute to the company's earnings diversification include traditional life, variable life, variable annuities, mutual funds, pensions and accident and health insurance. Risk-adjusted capitalization, as measured by Best's Capital Adequacy Ratio, is considered sufficient to support its current business and insurance risks. While volatility does exist in the operating profile of Aegon USA, the U.S. entities continue to maintain an underlying trend of profitability on both a statutory and IFRS basis.

A.M. Best notes that the company has made a strategic shift to focus on selling products such as variable annuities, mutual funds and 401(k)s and has de-emphasized spread-based products, particularly fixed annuities. In a relatively stable capital market environment, the required capital on variable annuities is generally less than that required for the fixed annuity/spread-based products. However, A.M. Best views variable annuities with living benefit riders as displaying some of the highest risk characteristics, as well as being vulnerable to tail risks, which could lead to an increase in required capital. In addition, the organization's increasing exposure to variable annuities exposes its earnings to volatility, and while hedged, Aegon USA's earnings remain somewhat correlated to capital market performance. A.M. Best also notes that Aegon USA has relied heavily on captive reinsurance to finance reserves generated from term life and universal life insurance with secondary guarantees. Financing provided to these captives include, but are not limited to, surplus notes, letters of credit and parental guarantees.

The rating actions on Transamerica Casualty acknowledge its ongoing profitability, ability to produce favorable investment yields, and role and strategic importance as a member of Aegon USA. Furthermore, Transamerica Casualty receives explicit reinsurance support provided by Transamerica Life Insurance Company and the benefits of receiving implied support if necessary in the future. In addition, the ratings recognize Transamerica Casualty's strong capitalization, the benefits it gains from relationships with affiliates and management's knowledge and expertise in the travel insurance market. Partially offsetting these positive factors are the company's elevated underwriting leverage and product concentration in a competitive market. The stable outlook reflects the continuation of operating profitability, expected favorable earnings opportunities, established business partnerships and a commitment to maintain a level of capitalization that is supportive of its ratings. A.M. Best believes Transamerica Casualty is well-positioned at its current rating level.

The outlooks have been revised to negative from stable and the FSR of A+ (Superior) and the Long-Term ICRs of "aa-" affirmed for the following members of Aegon USA Group:

quote:

A & A schreef op 10 augustus 2017 09:47:

Wat is ooit de hoogste koers geweest aegon

quote:

A & A schreef op 10 augustus 2017 15:23:

dan hebben we nog en helle weg te gaan

quote:

buf schreef op 9 november 2017 13:41:

nettowinst-onderliggende winst

1e kw. 2010 +372+446
2e kw. 2010 +413+522
3e kw. 2010 +657+473
4e kw. 2010 +318+489

1e kw. 2011 +327+441
2e kw. 2011 +404+401
3e kw. 2011 +060+361
4e kw. 2011 +081+346

1e kw. 2012 +521+425
2e kw. 2012 +254+443
3e kw. 2012 +374+472
4e kw. 2012 +422+447

1e kw. 2013 +204+445
2e kw. 2013 +243+478
3e kw. 2013 +227+531
4e kw. 2013 +174+491

1e kw. 2014 +392+498
2e kw. 2014 +343+514
3e kw. 2014 +052+291
4e kw. 2014 +399+562

1e kw. 2015 +316+469
2e kw. 2015 +350+549
3e kw. 2015 -524+436
4e kw. 2015 +478+486

1e kw. 2016 +143+462
2e kw. 2016 -385+435
3e kw. 2016 +358+461
4e kw. 2016 +470+554

1e kw. 2017 +378+488
2e kw. 2017 +529+535
3e kw. 2017 +469+556

prima nettowinst,
sterke solvabiliteit,
goede outlook.
Met de boekwinst van 180 miljoen in het vooruitzicht is een nettowinst van meer dan 600 miljoen in het 4e kwartaal zeker haalbaar.
We komen dan inderdaad voor 2017 op een winst per aandeel van 1 euro.
Dan moet toch een koers van 7 a 8 euro geen probleem zijn.
Ik houd de aandelen dan ook stevig vast.

quote:

FORT1944 schreef op 5 december 2017 09:16:

Die borrel , daar moeten we nog lang op wachten !